infliximab or placebo

DRUG2 trials

Sponsors

Centocor, Inc.

Conditions

Crohn Disease

Phase 3

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

CompletedNCT00207766

Centocor, Inc.Crohn Disease

Start: 2000-06-30End: 2006-08-31Updated: 2010-04-27

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

CompletedNCT00207662

Centocor, Inc.Crohn Disease

Start: 2000-07-31End: 2005-11-30Updated: 2010-04-27

Related Papers

C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I.

2012-01-18154 citations